연구성과로 돌아가기

2024 연구자 정보 (417 / 1079)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Ryu, Min-Hee
(Ryu, MH) ⓘ 		Univ Ulsan, Dept Gastroenterol, Asan Med Ctr, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea ⓘ
ⓘ 		0000-0002-1033-1263
Ryu, Min-Hee ⓘ 		[JCR상위 16.7] Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial
[JCR상위 1.0] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
[JCR상위 1.7] Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY ⓘ 		SCIE ⓘ 1.0 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY
GASTROENTEROLOGY & HEPATOLOGY
ONCOLOGY ⓘ 		ykkang@amc.seoul.kr;
msasako2010@yahoo.co.jp; ⓘ
Ryzhikh, Danila
(Ryzhikh, D) ⓘ 		제1저자 Kyungpook Natl Univ, KNU Inst Basic Sci, Dept Chem, KNU G LAMP Project Grp, Daegu 41566, South Korea ⓘ LZF-3319-2025
Ryzhikh, Danila ⓘ 		0009-0007-7429-9462
Ryzhikh, Danila ⓘ 		[JCR상위 16.7] On-DNA Mannich Reaction for DNA-Encoded Library Synthesis ⓘ SCIE ⓘ 16.7 CHEMISTRY, ORGANIC ⓘ msong@kmedihub.re.kr;giltae@knu.ac.kr; ⓘ
Schenker, Michael
(Schenker, M) ⓘ 		Centrul Oncol Sf Nectarie, Sect Oncol Med, Craiova, Romania ⓘ AAD-6920-2022
Schenker, Michael ⓘ
ⓘ 		[JCR상위 16.7] Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial ⓘ SCIE ⓘ 16.7 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY ⓘ ykkang@amc.seoul.kr; ⓘ
Seok, Jin Myoung
(Seok, JM) ⓘ 		제1저자 Soonchunhyang Univ, Coll Med, Dept Neurol, Hosp Cheonan, Cheonan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 16.7] Clinical Usefulness of a Cell-based Assay for Detecting Myelin Oligodendrocyte Glycoprotein Antibodies in Central Nervous System Inflammatory Disorders ⓘ SCIE ⓘ 16.7 MEDICAL LABORATORY TECHNOLOGY ⓘ juhongm@skku.edu; ⓘ
Son, Yeon-Su
(Son, YS) ⓘ 		KAIST Res Anal Ctr, Daejeon 34141, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 16.7] Silver tungstate-tellurite glass for radioactive iodine immobilization ⓘ SCIE ⓘ 16.7 MATERIALS SCIENCE, CERAMICS;MATERIALS SCIENCE, MULTIDISCIPLINARY ⓘ hyunwookang@kaeri.re.kr; ⓘ
Song, Minsoo
(Song, M) ⓘ 		교신저자 Daegu Gyeongbuk Med Innovat Fdn K MEDI hub, New Drug Dev Ctr NDDC, Daegu 41061, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 16.7] On-DNA Mannich Reaction for DNA-Encoded Library Synthesis ⓘ SCIE ⓘ 16.7 CHEMISTRY, ORGANIC ⓘ msong@kmedihub.re.kr;giltae@knu.ac.kr; ⓘ
Takashima, Atsuo
(Takashima, A) ⓘ 		Natl Canc Ctr, Tokyo, Japan ⓘ
ⓘ
ⓘ 		[JCR상위 16.7] Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial ⓘ SCIE ⓘ 16.7 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY ⓘ ykkang@amc.seoul.kr; ⓘ
Taylor, Kate
(Taylor, K) ⓘ 		Amgen Ltd, Uxbridge, England ⓘ
ⓘ
ⓘ 		[JCR상위 16.7] Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis ⓘ SCIE ⓘ 16.7 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY ⓘ ykkang@amc.seoul.kr; ⓘ
Waters, Patrick
(Waters, P) ⓘ 		Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford, England ⓘ
ⓘ 		0000-0003-4142-2667
Waters, Patrick ⓘ 		[JCR상위 16.7] Clinical Usefulness of a Cell-based Assay for Detecting Myelin Oligodendrocyte Glycoprotein Antibodies in Central Nervous System Inflammatory Disorders ⓘ SCIE ⓘ 16.7 MEDICAL LABORATORY TECHNOLOGY ⓘ juhongm@skku.edu; ⓘ
Wyrwicz, Lucjan
(Wyrwicz, L) ⓘ 		Inst Im Marii Sklodowskiej Curie, Klinika Onkol & Radioterapii 1, Ctr Onkol, Warsaw, Poland ⓘ
ⓘ
ⓘ 		[JCR상위 16.7] Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial ⓘ SCIE ⓘ 16.7 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY ⓘ ykkang@amc.seoul.kr; ⓘ
Yamaguchi, Kensei
(Yamaguchi, K) ⓘ 		JFCR, Gastroenterol Chemotherapy Dept, Canc Inst Hosp, Koto Ku, Tokyo, Japan ⓘ
ⓘ
ⓘ 		[JCR상위 16.7] Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis ⓘ SCIE ⓘ 16.7 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY ⓘ ykkang@amc.seoul.kr; ⓘ
Yan, Zhuchen
(Yan, ZC) ⓘ 		Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China ⓘ
ⓘ
ⓘ 		[JCR상위 16.7] Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis ⓘ SCIE ⓘ 16.7 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY ⓘ ykkang@amc.seoul.kr; ⓘ
Yang, Jae-Hwan
(Yang, JH) ⓘ 		Chungnam Natl Univ, Dept Environm Engn, Daejeon 34134, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 16.7] Silver tungstate-tellurite glass for radioactive iodine immobilization ⓘ SCIE ⓘ 16.7 MATERIALS SCIENCE, CERAMICS;MATERIALS SCIENCE, MULTIDISCIPLINARY ⓘ hyunwookang@kaeri.re.kr; ⓘ
Yi, Seonghoon
(Yi, S) ⓘ 		교신저자 Kyungpook Natl Univ, Dept Mat Sci & Met Engn, Daegu 41566, South Korea ⓘ HGC-6912-2022
Yi, Seonghoon ⓘ 		0000-0002-3746-3442
Yi, Seonghoon ⓘ 		[JCR상위 16.7] Enhanced thermoelectric performance of NbCoSb half-Heusler alloys by using an amorphous precursor
[JCR상위 8.9] Design strategy for high-entropy alloys with enhanced microstructural stability and mechanical properties for high-temperature applications ⓘ 		SCIE ⓘ 8.9 MATERIALS SCIENCE, CERAMICS;MATERIALS SCIENCE, MULTIDISCIPLINARY
MATERIALS SCIENCE, MULTIDISCIPLINARY;METALLURGY & METALLURGICAL ENGINEERING;NANOSCIENCE & NANOTECHNOLOGY ⓘ 		yish@knu.ac.kr;
krlim@kims.re.kr;yish@knu.ac.kr; ⓘ
Yimnirun, R.
(Yimnirun, R) ⓘ 		Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Energy Sci & Engn, Wangchan 21210, Rayong, Thailand
Vidyasirimedhi Inst Sci & TECHNOL VISTEC, Res Network NANOTEC VISTEC Nanotechnol Energy, Rayong 21210, Thailand
Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Energy Sci & Engn, Rayong 21210, Thailand ⓘ
ⓘ
ⓘ 		[JCR상위 16.7] Synthesis and characterization of eco-friendly, stable green-emitting Tb 3+-doped borosilicate glasses using waste silica gel
[JCR상위 36.6] Green development of samarium borosilicate glasses doped silica gel waste for stable orange colored visible host material
[JCR상위 6.1] Synthesis of eco-friendly borosilicate glass with Eu³⁺ dopants: Harnessing recovered silica gel waste for reddish-orange emission materials ⓘ 		SCIE ⓘ 6.1 MATERIALS SCIENCE, CERAMICS;MATERIALS SCIENCE, MULTIDISCIPLINARY
MATERIALS SCIENCE, MULTIDISCIPLINARY
CHEMISTRY, PHYSICAL;NUCLEAR SCIENCE & TECHNOLOGY;PHYSICS, ATOMIC, MOLECULAR & CHEMICAL ⓘ 		winzensio@gmail.com;pmanyum@sut.ac.th;jakrapong@webmail.npru.ac.th;
pmanyum@sut.ac.th;jakrapong@webmail.npru.ac.th;
winzensio@gmail.com;jakrapong@webmail.npru.ac.th; ⓘ
페이지 이동: